• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从感染到免疫治疗:宿主在膀胱黏膜对细菌的免疫反应。

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

机构信息

1] Unité d'Immunobiologie des Cellules Dendritiques, Department of Immunology, Institut Pasteur, Paris, France [2] INSERM U818, Department of Immunology, Institut Pasteur, Paris, France [3] Université Paris Descartes, Paris, France.

出版信息

Mucosal Immunol. 2013 Nov;6(6):1041-53. doi: 10.1038/mi.2013.72. Epub 2013 Sep 25.

DOI:10.1038/mi.2013.72
PMID:24064671
Abstract

The pathogenesis of urinary tract infection and mechanisms of the protective effect of Bacillus Calmette-Guerin (BCG) therapy for bladder cancer highlight the importance of studying the bladder as a unique mucosal surface. Innate responses to bacteria are reviewed, and although our collective knowledge remains incomplete, we discuss how adaptive immunity may be generated following bacterial challenge in the bladder microenvironment. Interestingly, the widely held belief that the bladder is sterile has been challenged recently, indicating the need for further study of the impact of commensal microorganisms on the immune response to uropathogen infection or intentional instillation of BCG. This review addresses the aspects of bladder biology that have been well explored and defines what still must be discovered about the immunobiology of this understudied organ.

摘要

尿路感染的发病机制和卡介苗(BCG)治疗膀胱癌的保护机制强调了研究膀胱作为独特黏膜表面的重要性。本文综述了对细菌的先天反应,尽管我们的集体知识仍然不完整,但我们讨论了在膀胱微环境中细菌挑战后如何产生适应性免疫。有趣的是,最近对膀胱无菌的普遍看法受到了挑战,这表明需要进一步研究共生微生物对尿路病原体感染或卡介苗有意灌输的免疫反应的影响。本综述探讨了膀胱生物学中已经得到充分研究的方面,并确定了关于这个研究不足的器官的免疫生物学仍需要发现的方面。

相似文献

1
From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.从感染到免疫治疗:宿主在膀胱黏膜对细菌的免疫反应。
Mucosal Immunol. 2013 Nov;6(6):1041-53. doi: 10.1038/mi.2013.72. Epub 2013 Sep 25.
2
Bladder resident macrophages: Mucosal sentinels.膀胱驻留巨噬细胞:黏膜哨兵。
Cell Immunol. 2018 Aug;330:136-141. doi: 10.1016/j.cellimm.2018.01.018. Epub 2018 Feb 2.
3
Bacillus Calmette-Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections.卡介苗免疫疗法治疗膀胱癌:免疫方面、临床疗效及卡介苗感染的综述。
APMIS. 2020 Feb;128(2):92-103. doi: 10.1111/apm.13011. Epub 2020 Jan 28.
4
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.你有经验吗?在复发性尿路感染的背景下理解膀胱固有免疫。
Curr Opin Infect Dis. 2015 Feb;28(1):97-105. doi: 10.1097/QCO.0000000000000130.
5
Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.卡介苗膀胱内灌注治疗非肌层浸润性膀胱癌:综述
Int J Urol. 2018 Jan;25(1):18-24. doi: 10.1111/iju.13410. Epub 2017 Jul 25.
6
Tissue Immunity in the Bladder.膀胱组织免疫。
Annu Rev Immunol. 2022 Apr 26;40:499-523. doi: 10.1146/annurev-immunol-101220-032117.
7
Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.脂质运载蛋白2对膀胱中的细菌生长施加选择性压力,并且在患有尿路感染的女性中水平升高。
J Immunol. 2014 Dec 15;193(12):6081-9. doi: 10.4049/jimmunol.1401528. Epub 2014 Nov 14.
8
Innate Immune Responses to Bladder Infection.先天性免疫对膀胱感染的反应。
Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.UTI-0024-2016.
9
Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.纤连蛋白介导卡介苗与小鼠膀胱黏膜的附着。抗肿瘤反应表达的必要性。
J Clin Invest. 1990 Jan;85(1):62-7. doi: 10.1172/JCI114434.
10
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches.膀胱癌,一种独特的模型,可用于了解癌症免疫并开发免疫疗法。
J Pathol. 2019 Oct;249(2):151-165. doi: 10.1002/path.5306. Epub 2019 Jun 24.

引用本文的文献

1
Progress on liposome delivery systems in the treatment of bladder cancer.脂质体递送系统在膀胱癌治疗中的研究进展
RSC Adv. 2025 May 6;15(18):14315-14336. doi: 10.1039/d5ra00746a. eCollection 2025 Apr 28.
2
Pathogenesis and Immunomodulation of Urinary Tract Infections Caused by Uropathogenic .由尿路致病性细菌引起的尿路感染的发病机制与免疫调节
Microorganisms. 2025 Mar 26;13(4):745. doi: 10.3390/microorganisms13040745.
3
Phytochemicals as Chemo-Preventive and Therapeutic Agents Against Bladder Cancer: A Comprehensive Review.
植物化学物质作为膀胱癌的化学预防和治疗剂:综述
Diseases. 2025 Mar 30;13(4):103. doi: 10.3390/diseases13040103.
4
A bladder blueprint to build better models for understanding homeostasis and disease.构建更好模型以理解体内平衡和疾病的膀胱蓝图。
Nat Rev Urol. 2025 Mar 26. doi: 10.1038/s41585-025-01013-x.
5
The role of the urinary microbiome in genitourinary cancers.泌尿微生物群在泌尿生殖系统癌症中的作用。
Nat Rev Urol. 2025 Mar 13. doi: 10.1038/s41585-025-01011-z.
6
Review of BCG immunotherapy for bladder cancer.卡介苗免疫疗法治疗膀胱癌的综述。
Clin Microbiol Rev. 2025 Mar 13;38(1):e0019423. doi: 10.1128/cmr.00194-23. Epub 2025 Feb 11.
7
CXCL16/CXCR6/TGF-β Feedback Loop Between M-MDSCs and Treg Inhibits Anti-Bacterial Immunity During Biofilm Infection.M-MDSCs与Treg之间的CXCL16/CXCR6/TGF-β反馈环在生物膜感染期间抑制抗菌免疫
Adv Sci (Weinh). 2025 Feb;12(7):e2409537. doi: 10.1002/advs.202409537. Epub 2024 Dec 24.
8
Inflammatory markers for improved recurrent UTI diagnosis in postmenopausal women.用于改善绝经后妇女复发性尿路感染诊断的炎症标志物。
Life Sci Alliance. 2024 Feb 8;7(4). doi: 10.26508/lsa.202302323. Print 2024 Apr.
9
BCG induced lower urinary tract symptoms during treatment for NMIBC-Mechanisms and management strategies.卡介苗在非肌层浸润性膀胱癌治疗期间引起的下尿路症状——机制与管理策略
Front Neurosci. 2024 Jan 8;17:1327053. doi: 10.3389/fnins.2023.1327053. eCollection 2023.
10
OncoTherad (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer: Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4 Signaling Pathway.OncoTherad (MRB-CFI-1) 纳米免疫疗法:治疗卡介苗无反应性非肌肉浸润性膀胱癌的有前途策略:T 细胞 CX3CR1、免疫检查点和 Toll 样受体 4 信号通路之间的串扰。
Int J Mol Sci. 2023 Dec 15;24(24):17535. doi: 10.3390/ijms242417535.